The global newborn screening market is primarily driven by the following factors:

1. Increasing prevalence of newborn diseases

2. Government support towards newborn child health

3. Rising awareness for pediatric congenital heart disease

4. Technological advancements in newborn screening

Global Newborn Screening LC-MS Reagent Kit Market: Key Takeaways

Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth. In the newborn screening, LC-MS/MS method is mainly applied to the detection of amino acids and acyl carnitines in blood.

Tandem mass spectrometry makes it possible to detect extremely low concentrations of compounds that can be used to indicate whether a baby is likely to have an inborn metabolic disorder.

Global Newborn Screening LC-MS Reagent Kit Market: Forecast by Type

The classification according to the material of Newborn Screening LC-MS Reagent Kit includes Non-derivatized Assay Solutions, Derivatized Assay Solutions, and the proportion of Non-derivatized Assay Solutions in 2017 is about 65.5%.

Newborn Screening LC-MS Reagent Kit is widely used to test Protein Metabolism, Fatty Acid Metabolism, Organic Acid Metabolism, the most proportion of Newborn Screening LC-MS Reagent Kit is used to test Protein Metabolism, and the proportion in 2017 is about 44.2%.

Global Newborn Screening LC-MS Reagent Kit Market: Forecast by Region

North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA are the seven regions that are included in this report. China is the largest sales place, with a sales market share nearly 21.8% in 2017. The demand for Newborn Screening LC-MS Reagent Kit in China is expected to witness growth owing to the increasing of newborn population.